1. Home
  2. Stocks
  3. Alkem Share Price
  • Chart
  • F&O
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Alkem Laboratories Share Price Alkem Laboratories

    Large Cap
    ₹4,586.4
    -64.45 (-1.39%)
    • Advice
    • Hold
    19 April, 2024 12:44 BSE: 539523 NSE: ALKEMISIN: INE540L01014

    Start SIP in Alkem Laboratories

    Start SIP

    Alkem Laboratories Performance

    Day Range

    • Low 4,567
    • High 4,645
    ₹ 4,586

    52 Week Range

    • Low 3,186
    • High 5,520
    ₹ 4,586
    • Open Price4,625
    • Previous Close4,651
    • Volume54997

    Alkem Laboratories Share Price

    • Over 1 Month -7.66%
    • Over 3 Month -6.88%
    • Over 6 Month +26.46%
    • Over 1 Year +36.46%

    Alkem Laboratories Key Statistics

    P/E Ratio 34.9
    PEG Ratio 0.6
    Market Cap Cr 54,837
    Price to Book Ratio 5.8
    EPS 95.7
    Dividend 1
    Relative Strength Index 32.69
    Money Flow Index 26.63
    MACD Signal -68.61
    Average True Range 127.56

    Alkem Laboratories F&O

    Alkem Laboratories Futures Alkem Laboratories Option Chain
    Alkem Laboratories Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 2,4952,6352,2532,238
    Operating Expenses Qtr Cr 1,9251,9801,9191,906
    Operating Profit Qtr Cr 569655334332
    Depreciation Qtr Cr 58595857
    Interest Qtr Cr 21192122
    Tax Qtr Cr 30-84775
    Net Profit Qtr Cr 504647271255
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 9,321
    Operating Expenses Annual Cr 7,678
    Operating Profit Annual in Cr 1,377
    Depreciation Cr 230
    Interest Annual Cr 86
    Tax Annual Cr 193
    Net Profit Annual Cr 1,134
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 1,437
    Cash from Investing Activity Annual Cr 197
    Cash from Financing Annual Activity Cr -1,711
    Net Cash Flow Annual Cr -77
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 9,350
    Fixed Assets Annual Cr 2,054
    Total Non Current Assets Annual Cr 5,959
    Total Current Assets Annual Cr 6,772
    Total Assets Annual Cr 12,731
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 782
    ROE Annual % 12
    ROCE Annual % 15
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 18
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3,3243,4402,9682,903
    Operating Expenses Qtr Cr 2,6162,6932,5792,549
    Operating Profit Qtr Cr 708747389353
    Depreciation Qtr Cr 70747278
    Interest Qtr Cr 25303029
    Tax Qtr Cr 513365144
    Net Profit Qtr Cr 59562128771
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 11,815
    Operating Expenses Annual Cr 9,990
    Operating Profit Annual in Cr 1,609
    Depreciation Cr 310
    Interest Annual Cr 107
    Tax Annual Cr 298
    Net Profit Annual Cr 984
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 1,683
    Cash from Investing Activity Annual Cr 113
    Cash from Financing Annual Activity Cr -1,761
    Net Cash Flow Annual Cr 35
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 9,045
    Fixed Assets Annual Cr 2,593
    Total Non Current Assets Annual Cr 5,027
    Total Current Assets Annual Cr 8,730
    Total Assets Annual Cr 13,757
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 789
    ROE Annual % 11
    ROCE Annual % 15
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 16
    Sign Up to Know More
    Invest in Alkem Laboratories

    Alkem Laboratories Technicals

    EMA & SMA

    Current Price
    ₹4,586.4
    -64.45 (-1.39%)
    pointer
    • Bullish Moving Average
    • ___
    • 3
    • Bearish Moving Average
    • ___
    • 13
    • 20 Day
    • ₹4,863.41
    • 50 Day
    • ₹4,943.03
    • 100 Day
    • ₹4,824.65
    • 200 Day
    • ₹4,480.49
    • 20 Day
    • ₹4,861.75
    • 50 Day
    • ₹5,055.53
    • 100 Day
    • ₹4,987.29
    • 200 Day
    • ₹4,374.72

    Alkem Laboratories Resistance and Support

    PIVOT
    ₹4,678.8
    Resistance
    First Resistance 4,721.20
    Second Resistance 4,791.55
    Third Resistance 4,833.95
    RSI 32.69
    MFI 26.63
    MACD Single Line -68.61
    MACD -87.26
    Support
    First Resistance 4,608.45
    Second Resistance 4,566.05
    Third Resistance 4,495.70

    Alkem Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 317,914 22,371,608 70.37
    Week 192,742 11,915,295 61.82
    1 Month 187,997 10,215,742 54.34
    6 Month 272,413 13,514,406 49.61

    Alkem Laboratories Result Highlights

    Alkem Laboratories Synopsis

    NSE-Medical-Diversified

    Alkem Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 9054.55 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2023. Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201.
    Market Cap 55,032
    Sales 9,620
    Shares in Float 5.14
    No of funds 270
    Yield 0.95
    Book Value 5.95
    U/D Vol ratio 0.9
    LTDebt / Equity
    Alpha 0.05
    Beta 0.75

    Alkem Laboratories

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 56.74%56.74%56.74%57.16%
    Mutual Funds 11.92%12.08%13.05%11.45%
    Insurance Companies 2.75%2.86%3.49%3.98%
    Foreign Portfolio Investors 9.11%8.49%6.03%5.63%
    Financial Institutions/ Banks
    Individual Investors 18.31%18.6%19.36%20.61%
    Others 1.17%1.23%1.33%1.17%

    Alkem Laboratories Management

    Name Designation
    Mr. Basudeo N Singh Executive Chairman
    Mr. Sandeep Singh Managing Director
    Mrs. Madhurima Singh Executive Director
    Mr. Srinivas Singh Executive Director
    Mr. Mritunjay Kumar Singh Executive Director
    Mr. Sarvesh Singh Executive Director
    Mr. Sujjain Talwar Independent Director
    Mr. Arun Kumar Purwar Independent Director
    Ms. Sangeeta Singh Independent Director
    Ms. Sudha Ravi Independent Director
    Dr. Dheeraj Sharma Independent Director
    Mr. Narendra Kumar Aneja Independent Director

    Alkem Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Alkem Laboratories Corporate Action

    Date Purpose Remarks
    2024-02-09 Quarterly Results & Interim Dividend
    2023-11-07 Quarterly Results
    2023-08-10 Quarterly Results
    2023-05-19 Audited Results & Final Dividend
    2023-02-10 Quarterly Results & Interim Dividend
    Date Purpose Remarks
    2024-02-17 INTERIM Rs.35.00 per share(1750%)Interim Dividend
    2023-08-10 FINAL Rs.10.00 per share(500%)Final Dividend
    2023-02-18 INTERIM Rs.15.00 per share(750%)Interim Dividend
    2023-02-18 SPECIAL Rs.25.00 per share(1250%)Special Dividend
    2022-08-10 FINAL Rs.4.00 per share(200%)Final Dividend

    Alkem Laboratories MF Shareholding

    Name Amount(cr)
    ICICI Prudential Bluechip Fund Growth 53,505
    ICICI Prudential Value Discovery Fund Growth 41,282
    Kotak Equity Arbitrage Fund Growth 40,051
    Kotak Emerging Equity Scheme Growth 39,685
    ICICI Prudential Multi-Asset Fund Growth 36,843

    Alkem Laboratories FAQs

    What is Share Price of Alkem Laboratories ?

    Alkem Laboratories share price is ₹4,586 As on 19 April, 2024 | 12:30

    What is the Market Cap of Alkem Laboratories ?

    The Market Cap of Alkem Laboratories is ₹54837.3 Cr As on 19 April, 2024 | 12:30

    What is the P/E ratio of Alkem Laboratories ?

    The P/E ratio of Alkem Laboratories is 34.9 As on 19 April, 2024 | 12:30

    What is the PB ratio of Alkem Laboratories ?

    The PB ratio of Alkem Laboratories is 5.8 As on 19 April, 2024 | 12:30

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.